Zinc-charged pancreatic enzymes for treatment of cancer and inflammation
US11371037B1 · kind B1 · utility
Assignee
Inventor
Key dates
| Filing date | Jul 13, 2021 |
| Grant date | Jun 28, 2022 |
| Priority date | — |
| Expiry date | Jul 13, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to pancreatic enzymes that have been charged with zinc ions, or zinc-charged pancreatic enzymes. Charging the pancreatic enzymes with zinc ions activate the pancreatic enzyme's anticancer and anti-inflammation properties and make the enzymes capable of being administered orally. It is observed that the zinc-charged pancreatic enzymes are able to induce apoptosis in various cancer cells without affecting the normal cells. The zinc-charged pancreatic enzymes have also been observed inducing apoptosis in trophoblasts and reducing inflammation in general. This invention is further directed to a method of preparing zinc-charged pancreatic enzymes. This invention is further directed to a method of treating cancer and inflammation using the zinc-charged pancreatic enzymes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.